RI
NVO

Ridgewood Investments’s Novo Nordisk NVO Stock Holding History

Ridgewood Investments’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.02M Sell
21,368
-3,281
-13% -$141K 0.38% 85
2026
Q1 		$906K Buy
+24,649
New +$1.17M 0.37% 86
2025
Q3 		$519K Buy
9,346
+2,719
+41% +$159K 0.22% 125
2025
Q2 		$457K Buy
6,627
+4,457
+205% +$303K 0.2% 122
2025
Q1 		$151K Buy
2,170
+1,495
+221% +$123K 0.07% 206
2024
Q4 		$58.1K Buy
+675
New +$73K 0.03% 286
2023
Q3 		– Sell
-28
Closed -$2.27K – 566
2023
Q2 		$2.27K Hold
28
– – ﹤0.01% 690
2023
Q1 		$2.23K Buy
+28
New +$1.99K ﹤0.01% 679

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Ridgewood Investments's NVO Position: Q2 2026 in Review

Ridgewood Investments reduced its Novo Nordisk (NVO) stake by 13% in Q2 2026, selling an estimated $141K and leaving 21,368 shares worth $1.02M. The position accounts for 0.38% of the portfolio, ranked #85.

Ridgewood Investments first reported a position in NVO in Q1 2023 and has held it in 8 quarters since. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Ridgewood Investments held 21,368 shares of Novo Nordisk worth $1.02M as of Q2 2026.
  • Ridgewood Investments sold 3,281 Novo Nordisk shares in Q2 2026, an estimated $141K.
  • Novo Nordisk made up 0.38% of Ridgewood Investments's portfolio in Q2 2026, its #85 holding.
  • Ridgewood Investments first reported a position in Novo Nordisk in Q1 2023 and has held it in 8 quarters since.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Ridgewood Investments's 13F filing for Q2 2026, filed 3 Aug 2026.